Krzysztof G.
- Country
- Poland
- Department
- Private Practice
Research Overview
- A Multicenter, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Budiodarone in Subjects with Non-permanent Atrial Fibrillation
- Evaluation of Intracoronary AB-1002 Efficacy and Safety in NYHA Class III Non-Ischemic Cardiomyopathy
- Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Data & Insights
Has run more than one trial at 29 of 282 partner sites.
Specializations
Cardiovascular Medicine
This investigator specializes in treating patients with atrial fibrillation, conducting research into innovative therapeutic approaches for managing cardiac arrhythmias.
- Cardiac Rhythm Disorders
- Stroke Prevention
- Anticoagulation Management
Their research activities focus on advancing treatment options for high-risk cardiac patients who face challenges with conventional anticoagulation therapies.
Thrombosis Research
The investigator's work centers on thromboembolic disease prevention, particularly in patients with complex cardiovascular conditions.
- Novel Anticoagulants
- Systemic Embolism Prevention
- High-Risk Patient Care
Their expertise extends to evaluating innovative therapeutic agents for preventing ischemic events in challenging clinical scenarios.
Clinical Therapeutics
The investigator explores alternative treatment strategies for patients who cannot receive standard anticoagulation therapy.
- Treatment Alternatives
- Patient Safety Protocols
- Cardiovascular Risk Management
Their research encompasses the development of therapeutic solutions for patients with limited treatment options due to contraindications to conventional therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.